CORE SCIENTIFIC INC ANNOUNCES COOPERATION AGREEMENT WITH TWO SEAS CAPITAL - SEC FILING
Cooperation Agreement: CORE Scientific has entered into a cooperation agreement with Two Seas Capital to enhance its operational capabilities.
Focus on Sec Filings: The agreement emphasizes the importance of SEC filings, indicating a commitment to regulatory compliance and transparency in operations.
Trade with 70% Backtested Accuracy
Analyst Views on CORZ
About CORZ
About the author


- Agreement on Customary Standards: Two parties have agreed to maintain customary standards that will remain effective for a one-year period.
- Post-Execution Provisions: The provisions will take effect after the execution of a cooperation agreement.

Core Scientific Appointments: Core Scientific plans to appoint two independent directors by 2026 to enhance its governance structure.
SEC Filing: The company is preparing for this change as part of its compliance with SEC regulations.

Cooperation Agreement: CORE Scientific has entered into a cooperation agreement with Two Seas Capital to enhance its operational capabilities.
Focus on Sec Filings: The agreement emphasizes the importance of SEC filings, indicating a commitment to regulatory compliance and transparency in operations.
- Executive Sell-off Impact: CoreWeave's CEO Michael Intrator sold 32,455 shares of Class A common stock worth $7.72 million on February 11, leading to downward pressure on the stock price, indicating market sensitivity to insider selling.
- Market Volatility Pressure: With the Nasdaq Composite down 0.09%, CoreWeave shares fell 5.83% to $90.44, highlighting the company's vulnerability amid broader market fluctuations.
- Upcoming Earnings Report: CoreWeave is set to report earnings on February 26, with an expected loss of 65 cents per share and revenue estimates of $1.53 billion, reflecting potential growth in the cloud infrastructure sector compared to last year's figures.
- Analyst Rating Dynamics: Despite short-term pressures, CoreWeave maintains a 'Buy' rating from several analysts, with Deutsche Bank raising its price target to $140, demonstrating confidence in the company's long-term prospects.
- New Investment Disclosure: On February 12, 2026, Oasis Management disclosed a new position by acquiring 2,643,729 shares of Core Scientific for $38.49 million, indicating a sustained interest in digital asset infrastructure.
- Holding Proportion Analysis: This acquisition represents approximately 2.5% of Oasis Management's reportable U.S. equity assets as of December 31, 2025, highlighting its strategic positioning in the digital infrastructure sector.
- Market Performance Review: As of February 12, 2026, Core Scientific shares were priced at $17.48, reflecting a 44.6% increase over the past year, outperforming the S&P 500 by 31.68 percentage points, suggesting positive market sentiment regarding its transformation.
- Financial Overview: Core Scientific's latest earnings report revealed a revenue decline to $81.1 million year-over-year; however, high-density colocation revenue increased from $10.3 million to $15.0 million, indicating a shift towards higher-margin service offerings.
- Stake Sale Overview: On February 13, 2026, Helix Partners Management LP disclosed in an SEC filing the sale of its entire 200,000-share stake in SLM Corporation for approximately $5.54 million, indicating a cautious outlook on the company's future performance.
- SLM Financial Status: As of February 12, 2026, SLM shares were priced at $24.76, reflecting a 14.6% decline over the past year, and underperforming the S&P 500 by 27.5 percentage points during the same period, raising concerns about its growth potential.
- Investor Considerations: Despite SLM achieving a GAAP diluted EPS of $3.46 and a net interest margin of 5.21% in 2025, the delinquency rate rose to 4.0%, with guidance for net charge-offs in 2026 projected between $345 million and $385 million, signaling a trend of credit normalization.
- Future Outlook: Helix Partners' decision to trim its position may reflect a cautious stance on SLM's growth prospects, even as the company remains profitable and well-capitalized, prompting investors to focus on capital returns and credit metrics to assess the viability of holding the stock.







